Press releases
Press releases.
January 30th 2024
Immutep Quarterly Activities Report Q2 FY24
Investor updates
Analyst reports
Analyst reports.
March 6th 2024
Ladenburg Thalmann - Next Is Dose Optimization for BC Program; Reiterate Buy, $8.30 PT (Analyst: Ahu Demir, PhD)
March 6th 2024